MRK
Merck & Co., Inc. · Healthcare
Exec Chair Kenneth C Frazier sold $46.4M of Merck & Co., Inc.
Sold$46,372,118
$98.66Price
470,000Shares
−40%Stake
What MRK did after the filing
- The stock from Mon, Nov 7 close, $100.07
- +9.6%
- S&P 500, same days
- +0.6%
Measured over 30 trading days, to the Dec 20 close.
Traded Thu, Nov 3. Filed Mon, Nov 7, 11:06 AM ET, during the session. Returns use the Nov 7 close and the Dec 20 close. Not investment advice.